Deals of the day-Mergers and acquisitions
Nov 26 (Reuters) -The following bids, mergers, acquisitions, and disposals were reported by 1030 GMT on Tuesday:
** Switzerland's Roche ROG.S will acquire its U.S. collaboration partner Poseida Therapeutics PSTX.O in a cash deal worth up to $1.5 billion, banking on complex immune cell therapies against several types of blood cancer to boost its development pipeline.nL2N3MX07R
** Affinity Equity Partners, a Hong Kong-based buyout firm, has concluded two acquisitions in Southeast Asia worth a combined $1.65 billion, people with knowledge of the deals said.nL3N3MX0DK
** Qualcomm's QCOM.O interest in acquiring Intel INTC.O is said to have cooled due to complexities associated with the deal, Bloomberg News reported on Monday, citing people familiar with the matter.nL3N3MX072
** Cloud-based streaming platform Brightcove BCOV.O said on Monday that Bending Spoons will buy the company in a transaction valued at about $233 million, adding to a string of deals by the Italian tech firm as it bolsters its app portfolio.nL3N3MW0UI
** Abu Dhabi's Mubadala Capital will take CI Financial CIX.TO private in a C$12.1 billion ($8.66 billion) all-cash deal, including debt, the Canadian asset and wealth manager said on Monday.nL3N3MW0LH
** Regional lender Old National Bancorp ONB.O will buy privately held Bremer Financial in a $1.40 billion cash-and-stock deal, the companies said on Monday, creating a combined bank with over $70 billion in assets.nL3N3MW0JO
** Summit Materials SUM.N said on Monday that rival Quikrete would acquire the company in a deal valued at $11.5 billion, in a move to capitalize on higher demand for building materials.nL3N3MW0L7
(Compiled by Rajarshi Roy and Kamal Choudhury in Bengaluru)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
